LEX 028
Alternative Names: LEX-028Latest Information Update: 16 Nov 2006
Price :
$50 *
At a glance
- Originator Lexin
- Class Anti-inflammatories
- Mechanism of Action Cathepsin G inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 07 Sep 1998 No-Development-Reported for Inflammation in USA (Unknown route)
- 29 Aug 1996 Preclinical development for Inflammation in USA (Unknown route)